Light Horse emerges with $62m and Novartis partnership worth up to $1bn
Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.
TMCnet1h
CI Financial Announces Filing and Mailing of Circular for Special Meeting to Approve Plan of Arrangement with Mubadala Capital
CI Financial Corp. ("CI" or the "Corporation") (TSX: CIX) today announced the commencement of the mailing of its management information circular and related shareholder meeting materials for the ...